Holen Sie sich die Stockscreener-App
11.13
1.24%
-0.14
Handel nachbörslich:
11.26
0.13
+1.17%
Schlusskurs vom Vortag:
$11.27
Offen:
$11.34
24-Stunden-Volumen:
1.09M
Relative Volume:
0.77
Marktkapitalisierung:
$1.70B
Einnahmen:
$113.31M
Nettoeinkommen (Verlust:
$-57.51M
KGV:
-20.24
EPS:
-0.55
Netto-Cashflow:
$-20.55M
1W Leistung:
-14.91%
1M Leistung:
-17.19%
6M Leistung:
+98.04%
1J Leistung:
+122.60%
1-Tages-Spanne:
$11.10
$11.44
1-Wochen-Bereich:
$10.57
$13.07
52-Wochen-Spanne:
$3.50
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
11.13 | 1.70B | 113.31M | -57.51M | -20.55M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.66 | 106.01B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
690.87 | 75.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.60 | 39.80B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.51 | 31.02B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
112.43 | 26.95B | 3.30B | -501.07M | 1.03B | -2.1146 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Wants To Put The Joy Back Into Weight-Loss Drugs - Scrip
Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential? - Yahoo Finance
Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation - GlobeNewswire
Wave Life Sciences Advances Obesity Drug WVE-007, Reports Strong DMD Treatment Results - StockTitan
Barclays PLC Has $1.31 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey
WAVE Life Sciences (FRA:1U5) Cash From Discontinued Investi - GuruFocus.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.22 Average Target Price from Brokerages - MarketBeat
12 Best Growth Stocks Under $25 to Buy Now - Insider Monkey
Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25? - Yahoo Finance
How to Take Advantage of moves in (WVE) - Stock Traders Daily
Wave Life Sciences Is A Buy On Pipeline Prospects (WVE) - Seeking Alpha
Wave Life Sciences (NASDAQ:WVE) Trading Down 4%Here's What Happened - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Stock Price Up 7.7%What's Next? - MarketBeat
Learn to Evaluate (WVE) using the Charts - Stock Traders Daily
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Barclays PLC - MarketBeat
Geode Capital Management LLC Increases Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Stock Price Down 2.6%Here's Why - MarketBeat
Wave files clinical trial application for WVE-007 - BioWorld Online
State Street Corp Has $19.03 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity - The Manila Times
Wave Life Sciences Announces Submission of First Clinical - GlobeNewswire
Wave Life Sciences Advances Novel Obesity Drug WVE-007 Targeting INHBE Gene; Clinical Trials Set for 2025 - StockTitan
WAVE Life Sciences (FRA:1U5) Other Long-Term Liabilities : €7.09 Mil (As of Sep. 2024) - GuruFocus.com
WAVE Life Sciences (FRA:1U5) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(WVE) Investment Analysis - Stock Traders Daily
Y Intercept Hong Kong Ltd Has $242,000 Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wellington Management Group LLP Reduces Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal year - Investing.com Australia
Point72 Asset Management L.P. Has $230,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Neurological stocks rise and fall on clinical data; index down - BioWorld Online
Fmr LLC Raises Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis - Dalal Street Investment Journal
Jacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Duchenne Muscular Dystrophy Pipeline Insights 2024: - openPR
RTW Investments LP Makes New Investment in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
486,023 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Polar Asset Management Partners Inc. - MarketBeat
Maven Securities LTD Purchases Shares of 850,000 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Cinctive Capital Management LP Has $2.92 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Baker BROS. Advisors LP Invests $2.82 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Walleye Capital LLC Invests $4.94 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
WAVE Life Sciences (STU:1U5) Pre-Tax Income : €-130.19 Mil (TTM As of Sep. 2024) - GuruFocus.com
WAVE Life Sciences (FRA:1U5) Financial Strength : 6 (As of Sep. 2024) - GuruFocus.com
Wave Life Sciences CEO Paul Bolno sells $750,000 in shares - Investing.com India
Wave Life Sciences CEO Paul Bolno sells $750,000 in shares By Investing.com - Investing.com Canada
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):